Washington Trust Company Cut By $13.04 Million Its General Electric Co (GE) Stake; Core Laboratories LP (CLB) Has 1.07 Sentiment

December 7, 2017 - By Vivian Park

Washington Trust Company decreased General Electric Co (GE) stake by 61.53% reported in 2017Q2 SEC filing. Washington Trust Company sold 482,976 shares as General Electric Co (GE)’s stock declined 7.64%.

The Washington Trust Company holds 301,975 shares with $8.16M value, down from 784,951 last quarter. General Electric Co now has $153.15 billion valuation. The stock decreased 0.56% or $0.1 during the last trading session, reaching $17.66. About 43.91 million shares traded. General Electric Company (NYSE:GE) has declined 4.46% since December 7, 2016 and is downtrending. It has underperformed by 21.16% the S&P500.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the gas and oil industry in the United States, Canada, and internationally. The company has market cap of $4.36 billion. It operates through three divisions: Reservoir Description, Production Enhancement, and Reservoir Management. It has a 56.7 P/E ratio. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples.

Wcm Investment Management Ca holds 6.93% of its portfolio in Core Laboratories N.V. for 4.43 million shares. Wedgewood Partners Inc owns 1.26 million shares or 3.91% of their US portfolio. Moreover, Underhill Investment Management Llc has 3.74% invested in the company for 58,395 shares. The New York-based Riverpark Advisors Llc has invested 3.64% in the stock. Sustainable Growth Advisers Lp, a Connecticut-based fund reported 2.35 million shares.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on January, 24. They expect $0.58 EPS, up 41.46% or $0.17 from last year’s $0.41 per share. CLB’s profit will be $25.60 million for 42.52 P/E if the $0.58 EPS becomes a reality. After $0.48 actual EPS reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 20.83% EPS growth.

The stock decreased 3.63% or $3.72 during the last trading session, reaching $98.65. About 616,944 shares traded or 0.98% up from the average. Core Laboratories N.V. (CLB) has declined 5.82% since December 7, 2016 and is downtrending. It has underperformed by 22.52% the S&P500.

Among 25 analysts covering General Electric Company (NYSE:GE), 10 have Buy rating, 5 Sell and 10 Hold. Therefore 40% are positive. General Electric Company had 78 analyst reports since July 21, 2015 according to SRatingsIntel. CFRA downgraded General Electric Company (NYSE:GE) on Friday, July 21 to “Hold” rating. The stock of General Electric Company (NYSE:GE) earned “Sell” rating by Deutsche Bank on Monday, October 30. The firm has “Buy” rating given on Wednesday, October 14 by S&P Research. RBC Capital Markets maintained it with “Buy” rating and $31.0 target in Friday, September 15 report. The firm earned “Equal-Weight” rating on Tuesday, July 25 by Morgan Stanley. Oppenheimer maintained General Electric Company (NYSE:GE) on Monday, July 17 with “Hold” rating. The stock has “Outperform” rating by Credit Suisse on Thursday, October 5. The stock has “Buy” rating by TheStreet on Wednesday, August 26. Langenberg upgraded General Electric Company (NYSE:GE) rating on Monday, November 13. Langenberg has “Buy” rating and $25 target. The stock of General Electric Company (NYSE:GE) has “Focus List” rating given on Wednesday, September 16 by Credit Suisse.

Analysts await General Electric Company (NYSE:GE) to report earnings on January, 19. They expect $0.28 earnings per share, down 39.13% or $0.18 from last year’s $0.46 per share. GE’s profit will be $2.43 billion for 15.77 P/E if the $0.28 EPS becomes a reality. After $0.29 actual earnings per share reported by General Electric Company for the previous quarter, Wall Street now forecasts -3.45% negative EPS growth.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>